Related Experiment Video
Updated: Jul 14, 2026
07:40
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
A cholinergic agonist attenuates endotoxin-induced uveitis in rats
Zai-Long Chi1, Seiji Hayasaka, Xue-Yun Zhang
1Department of Ophthalmology, Graduate School of Medicine, University of Toyama, Toyama, Japan. ophthal@med.u-toyama.ac.jp
Investigative Ophthalmology & Visual Science
|May 26, 2007
Summary
Nicotine reduces inflammation in endotoxin-induced uveitis (EIU) by lowering key inflammatory molecules in the eye. This suggests the nicotinic anti-inflammatory pathway plays a role in EIU pathogenesis.
Area of Science:
- Ophthalmology
- Immunology
- Pharmacology
Background:
- Investigating physiological anti-inflammatory mechanisms is crucial for treating inflammatory disorders.
- Cholinergic agonists, like nicotine, offer potential therapeutic avenues.
- Endotoxin-induced uveitis (EIU) serves as a model for ocular inflammation.
Purpose of the Study:
- To investigate nicotine's effect on endotoxin-induced uveitis (EIU) in rats.
- To elucidate the underlying molecular mechanisms of nicotine's action in EIU.
- To assess the role of the alpha7 nicotine acetylcholine receptor (alpha7nAChR) pathway.
Main Methods:
- EIU was induced in rats using lipopolysaccharide (LPS).
- Nicotine was administered intraperitoneally, and clinical scores, protein, and cell counts in aqueous humor were assessed.
- Expression of alpha7nAChR, cytokines (IL-6, IL-1beta, TNF-alpha, IL-10), and chemokines (CINC-1, MCP-1) was measured using immunohistochemistry, real-time PCR, and ELISA.
Main Results:
- LPS injection significantly increased clinical scores, aqueous humor protein, and cell counts.
- Nicotine administration attenuated these LPS-induced increases.
- Nicotine decreased elevated levels of IL-6, IL-1beta, TNF-alpha, CINC-1, and MCP-1 in serum and aqueous humor, but not IL-10. Alpha7nAChR expression increased with LPS and/or nicotine.
- Nicotine did not affect endotoxin-induced elevation of mRNA levels in the iris and ciliary body.
Conclusions:
- Nicotine effectively attenuated EIU by reducing pro-inflammatory cytokines and chemokines in the aqueous humor.
- The anti-inflammatory effects of nicotine were mediated directly on these molecules, not at the mRNA level in ocular tissues.
- These findings highlight the involvement of the nicotinic anti-inflammatory pathway in EIU pathogenesis, suggesting potential therapeutic applications.
Related Concept Videos
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...